Effect of compounds 3a-r and selegiline in 1 μМ concentration on the activity of hMAO-B. *** Р < 0.001 compared to control (pure hMAO-B).

 
 
  Part of: Kondeva-Burdina M, Krastev K, Pencheva T, Angelova VT (2025) Indole-based hydrazide-hydrazone and sulfonylhydrazone derivatives as MAO-B inhibitors with multitarget potential for neurodegenerative diseases. Pharmacia 72: 1-13. https://doi.org/10.3897/pharmacia.72.e155372